Literature DB >> 30928366

An update of ophthalmic management in craniosynostosis.

Anuradha Ganesh1, Jane Edmond2, Brian Forbes3, William R Katowitz4, Ken K Nischal5, Marilyn Miller6, Alex V Levin7.   

Abstract

Craniosynostosis has a varied clinical spectrum, ranging from isolated single suture involvement to multisutural fusions. Syndromic and nonsyndromic patients require orchestrated and multidisciplinary care from birth to adulthood. Advances in our understanding of craniosynostosis over the last quarter-century have resulted in more systematic management of the problems associated with the syndromic and nonsyndromic forms of this condition. This review provides an update on the genetic basis of, management of strabismus and oculoplastic manifestations in, and visual surveillance of patients with craniosynostosis.
Copyright © 2019 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30928366     DOI: 10.1016/j.jaapos.2018.10.016

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  4 in total

1.  Computer tomography-based quantitative analysis of the orbital proptosis severity in infants with syndromic craniosynostosis: case-control study.

Authors:  Rosalinda Calandrelli; Fabio Pilato; Antonio Marrazzo; Luca Massimi; Marco Panfili; Concezio Di Rocco; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2021-02-08       Impact factor: 1.475

2.  Clinical study and some molecular features of Mexican patients with syndromic craniosynostosis.

Authors:  Aurora Ibarra-Arce; Manuel Almaraz-Salinas; Víctor Martínez-Rosas; Gabriela Ortiz de Zárate-Alarcón; Laura Flores-Peña; Mirza Romero-Valdovinos; Angélica Olivo-Díaz
Journal:  Mol Genet Genomic Med       Date:  2020-06-08       Impact factor: 2.183

3.  Ophthalmological outcomes of unilateral coronal synostosis in young children.

Authors:  Wen-Ting Luo; Xin Chen; Yi-Dan Zhang; Qing-Yu Liu; Tong Qiao
Journal:  BMC Ophthalmol       Date:  2020-08-04       Impact factor: 2.209

4.  Effect of Fibroblast Growth Factor 2 on Extraocular Muscle Structure and Function.

Authors:  Jolene C Rudell; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.